Clinical Trials
15
Active:5
Completed:6
Trial Phases
2 Phases
Phase 1:10
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (71.4%)Phase 2
4 (28.6%)Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- GH Research Ireland Limited
- Target Recruit Count
- 52
- Registration Number
- NCT06511947
- Locations
- 🇬🇧
GH Research Clinical Trial Site, London, United Kingdom
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- GH Research Ireland Limited
- Target Recruit Count
- 6
- Registration Number
- NCT05839509
- Locations
- 🇬🇧
Investigational Site, London, United Kingdom
🇬🇧Investigation Site, Oxford, United Kingdom
Phase 2 Clinical Trial of GH001 in Postpartum Depression
- First Posted Date
- 2023-04-07
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- GH Research Ireland Limited
- Target Recruit Count
- 10
- Registration Number
- NCT05804708
- Locations
- 🇳🇱
Amsterdam UMC, Amsterdam, Netherlands
🇬🇧Clerkenwell Health, London, United Kingdom
🇬🇧St. Pancras Clinical Research, London, United Kingdom
A Trial of GH001 in Patients With Treatment-resistant Depression
- First Posted Date
- 2023-04-06
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- GH Research Ireland Limited
- Target Recruit Count
- 81
- Registration Number
- NCT05800860
- Locations
- 🇮🇪
Investigational site, Dublin, Ireland
🇪🇸Investigational Site, Salamanca, Spain
Safety and Pharmacokinetics of GH002 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- GH Research Ireland Limited
- Target Recruit Count
- 64
- Registration Number
- NCT05753956
- Locations
- 🇳🇱
GH Research Clinical Trial Site, Groningen, Netherlands
- Prev
- 1
- 2
- Next
News
No news found